BACKGROUND: In patients with primary hyperaldosteronism, distinguishing between unilateral and bilateral adrenal hypersecretion is critical in assessing treatment options. Adrenal venous sampling (AVS) has been advocated by some to be the gold standard for localization of the responsible lesion, but there remains a lack of consensus for the criteria and the standardization of technique. STUDY DESIGN: We performed a retrospective study of 114 patients with a biochemical diagnosis of primary hyperaldosteronism who all underwent CT scan and AVS before and after corticotropin (ACTH) stimulation. Univariate and multivariate analyses were performed to determine what factors were associated with AVS lateralization, and which AVS values were the most accurate criteria for lateralization. RESULTS: Eighty-five patients underwent surgery at our institution for unilateral hyperaldosteronism. Of the 57 patients who demonstrated unilateral abnormalities on CT, AVS localized to the contralateral side in 5 patients and revealed bilateral hyperplasia in 6 patients. Of the 52 patients who showed bilateral disease on CT scan, 43 lateralized with AVS. The most accurate criterion on AVS for lateralization was the post-ACTH stimulation value. Factors associated with AVS lateralization included a low renin value, high plasma aldosterone-to plasma-renin ratio, and adrenal mass > or = 3 cm on CT scan. CONCLUSIONS: Because 50% of patients would have been inappropriately managed based on CT scan findings, patients with biochemical evidence of primary hyperaldosteronism and considering adrenalectomy should have AVS. The most accurate measurement for AVS lateralization was the post-ACTH stimulation value. Although several factors predict successful AVS lateralization, none are accurate enough to perform AVS selectively.
BACKGROUND: In patients with primary hyperaldosteronism, distinguishing between unilateral and bilateral adrenal hypersecretion is critical in assessing treatment options. Adrenal venous sampling (AVS) has been advocated by some to be the gold standard for localization of the responsible lesion, but there remains a lack of consensus for the criteria and the standardization of technique. STUDY DESIGN: We performed a retrospective study of 114 patients with a biochemical diagnosis of primary hyperaldosteronism who all underwent CT scan and AVS before and after corticotropin (ACTH) stimulation. Univariate and multivariate analyses were performed to determine what factors were associated with AVS lateralization, and which AVS values were the most accurate criteria for lateralization. RESULTS: Eighty-five patients underwent surgery at our institution for unilateral hyperaldosteronism. Of the 57 patients who demonstrated unilateral abnormalities on CT, AVS localized to the contralateral side in 5 patients and revealed bilateral hyperplasia in 6 patients. Of the 52 patients who showed bilateral disease on CT scan, 43 lateralized with AVS. The most accurate criterion on AVS for lateralization was the post-ACTH stimulation value. Factors associated with AVS lateralization included a low renin value, high plasma aldosterone-to plasma-renin ratio, and adrenal mass > or = 3 cm on CT scan. CONCLUSIONS: Because 50% of patients would have been inappropriately managed based on CT scan findings, patients with biochemical evidence of primary hyperaldosteronism and considering adrenalectomy should have AVS. The most accurate measurement for AVS lateralization was the post-ACTH stimulation value. Although several factors predict successful AVS lateralization, none are accurate enough to perform AVS selectively.
Authors: Gregory A Kline; Adrian Harvey; Charlotte Jones; Michael H Hill; Benny So; Nairne Scott-Douglas; Janice L Pasieka Journal: Int Urol Nephrol Date: 2008-08-12 Impact factor: 2.370
Authors: Rasa Zarnegar; William F Young; James Lee; Matthew P Sweet; Electron Kebebew; David R Farley; Geoffrey B Thompson; Clive S Grant; Orlo H Clark; Quan-Yang Duh Journal: Ann Surg Date: 2008-03 Impact factor: 12.969
Authors: William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden Journal: Surgery Date: 2004-12 Impact factor: 3.982
Authors: Paul Milliez; Xavier Girerd; Pierre-François Plouin; Jacques Blacher; Michel E Safar; Jean-Jacques Mourad Journal: J Am Coll Cardiol Date: 2005-04-19 Impact factor: 24.094
Authors: Rasa Zarnegar; Alan I Bloom; James Lee; Robert K Kerlan; Mark W Wilson; Jeanne M Laberge; Roy L Gordon; Electron Kebebew; Orlo H Clark; Quan-Yang Duh Journal: J Vasc Interv Radiol Date: 2008-01 Impact factor: 3.464
Authors: John W Funder; Robert M Carey; Carlos Fardella; Celso E Gomez-Sanchez; Franco Mantero; Michael Stowasser; William F Young; Victor M Montori Journal: J Clin Endocrinol Metab Date: 2008-06-13 Impact factor: 5.958
Authors: Marlies J E Kempers; Jacques W M Lenders; Lieke van Outheusden; Gert Jan van der Wilt; Leo J Schultze Kool; Ad R M M Hermus; Jaap Deinum Journal: Ann Intern Med Date: 2009-09-01 Impact factor: 25.391
Authors: Christoph Degenhart; Hanna Strube; Matthias J Betz; Anna Pallauf; Martin Bidlingmaier; Evelyn Fischer; Martin Reincke; Maximilian F Reiser; Stefan Wirth Journal: Diagn Interv Radiol Date: 2015 Jan-Feb Impact factor: 2.630
Authors: Naris Nilubol; Steven J Soldin; Dhaval Patel; Muthoni Rwenji; Jianghong Gu; Likhona S Masika; Richard Chang; Constantine A Stratakis; Electron Kebebew Journal: Int J Endocr Oncol Date: 2017-04-27
Authors: Tracy S Wang; Greg Kline; Tina W Yen; Ziyan Yin; Ying Liu; William Rilling; Benny So; James W Findling; Douglas B Evans; Janice L Pasieka Journal: World J Surg Date: 2018-02 Impact factor: 3.352
Authors: Richard Webb; Aarti Mathur; Richard Chang; Smita Baid; Naris Nilubol; Steven K Libutti; Constantine A Stratakis; Electron Kebebew Journal: Ann Surg Oncol Date: 2011-11-03 Impact factor: 5.344
Authors: Jin Young Kim; See Hyung Kim; Hee Jung Lee; Young Hwan Kim; Mi Jeong Kim; Seung Hyun Cho Journal: Diagn Interv Radiol Date: 2014 Jan-Feb Impact factor: 2.630